CN Patent

CN106892864A — 一种奈妥皮坦游离碱的晶型a及其制备方法

Assigned to SHANGHAI SYNCORES TECHNOLOGIES Inc · Expires 2017-06-27 · 9y expired

What this patent protects

本发明公开了一种的2-(3,5-二三氟甲基苯基)-N-甲基-N-[6-(4-甲基哌嗪-1-基)-4-邻甲苯基吡啶-3-基]-异丁酰胺游离碱的新晶型A、药物组合物及其制备方法，该晶型A稳定性好，且其制备方法简单、易于操作。

USPTO Abstract

本发明公开了一种的2-(3,5-二三氟甲基苯基)-N-甲基-N-[6-(4-甲基哌嗪-1-基)-4-邻甲苯基吡啶-3-基]-异丁酰胺游离碱的新晶型A、药物组合物及其制备方法，该晶型A稳定性好，且其制备方法简单、易于操作。

Drugs covered by this patent

fosnetupitant-chloride-hydrochloride (FOSNETUPITANT CHLORIDE HYDROCHLORIDE)

Patent Metadata

Patent number: CN106892864A
Jurisdiction: CN
Classification: —
Expires: 2017-06-27
Drug substance claim: No
Drug product claim: No
Assignee: SHANGHAI SYNCORES TECHNOLOGIES Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.